Avantor, Inc. (New York Stock Exchange:AVTR)
| Market Cap | $10.06B+28.8% |
| Revenue (ttm) | $6.64B+0.9% |
| Net Income | $337.20M+510.2% |
| EPS | $0.50+515.3% |
| Shares Out | 677.62M |
| PE Ratio | 29.61 |
| Forward PE | 16.70 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 12,253,271 |
| Open | $15.11 |
| Previous Close | $15.12 |
| Day's Range | $14.79 - $15.50 |
| 52-Week Range | $7.26 - $17.45 |
| Beta | 0.95 |
| Analysts | Hold |
| Price Target | $14.55(-1.95%) |
| Earnings Date | Feb 10, 2027 |
About AVTR
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
7 firms rating AVTR in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Feb 10, 2027Earnings report
$AVTR stock is featured in our Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of AVTR by members of U.S. Congress
| Gilbert Ray CisnerosHouse / D | Sale$1.00K – $15.00K | Aug 13, 2025 |
| Gilbert CisnerosHouse / D | Sale$1.00K – $15.00K | Aug 13, 2025 |
| Gilbert Ray CisnerosHouse / D | Sale$1.00K – $15.00K | Aug 12, 2025 |
| Gilbert CisnerosHouse / D | Sale$1.00K – $15.00K | Aug 12, 2025 |
| Gilbert Ray CisnerosHouse / D | Sale$1.00K – $15.00K | Aug 11, 2025 |
| Gilbert Ray CisnerosHouse / D | Sale$1.00K – $15.00K | Jul 23, 2025 |
| Gilbert CisnerosHouse / D | Sale$1.00K – $15.00K | Jul 23, 2025 |
| Lisa C. McClainHouse / R | Sale$1.00K – $15.00K | Jun 17, 2025 |
Recently reported changes in AVTR holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by AVTR's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
AVTR Estimated quarterly lobbying spending
Source: U.S. Senate LDA
AVTR Revenue by Segment or Geography
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New AVTR patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to AVTR from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in AVTR
| IJHiShares Core S&P Mid-Cap ETF | $368.52M |
| VTIVanguard Morningstar Total Stock Market ETF | $271.92M |
| VBVanguard Morningstar Small-Cap ETF | $243.37M |
| DFSVU.S. Small Cap Value Portfolio ETF Class Shares | $161.12M |
| VBRVanguard Morningstar Small-Cap Value ETF | $158.20M |
| VXFVanguard Extended Market ETF | $123.13M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from AVTR’s recent data — informational, not investment advice
What’s Behind the Score
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| ADPV | Adaptiv Select ETF | 4.17% |
| PINK | Simplify Health Care ETF | 3.84% |
| EPSB | Harbor SMID Cap Core ETF (EPSB) | 2.08% |
| LSEQ | Harbor Long-Short Equity ETF (LSEQ) | 1.47% |
| XHYH | BondBloxx USD High Yield Bond Healthcare Sector ETF | 1.22% |
| TSNF | Truth Social American Next Frontiers ETF | 1.19% |
| HXE | Mast HedgeIndex Adaptive Equities ETF | 1.04% |
| NIXT | Research Affiliates Deletions ETF | 0.83% |
| NUSC | Nuveen ESG Small-Cap ETF | 0.80% |
| JHMH | John Hancock Multifactor Health Care ETF | 0.64% |
| IVOV | Vanguard S&P Mid-Cap 400 Value ETF | 0.63% |
| SYG | SPDR MFS Systematic Growth Equity ETF | 0.61% |
Weight is the stock’s share of each fund’s holdings.
